ResMed
501 hedge funds and large institutions have $11B invested in ResMed in 2018 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 189 increasing their positions, 172 reducing their positions, and 60 closing their positions.
57% more funds holding in top 10
Funds holding in top 10: 7 → 11 (+4)
12% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 60
2.66% more ownership
Funds ownership: 66.02% → 68.68% (+2.7%)
10% more repeat investments, than reductions
Existing positions increased: 189 | Existing positions reduced: 172
2% more capital invested
Capital invested by funds: $10.9B → $11B (+$182M)
1% more funds holding
Funds holding: 497 → 501 (+4)
11% less call options, than puts
Call options by funds: $31.7M | Put options by funds: $35.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$463M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$75.8M |
| 3 |
BlackRock
New York
|
+$62.6M |
| 4 |
O
OppenheimerFunds
New York
|
+$45.1M |
| 5 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$35.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$88.1M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$82.5M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$68.4M |
| 4 |
Renaissance Technologies
New York
|
-$44.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$41.2M |
RMD Hedge Fund Activity: Q4 2018 in Review
501 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q4 2018, worth a combined $11B — up 1.7% from $10.9B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new RMD positions and 60 closed out — a net gain of 7 holders — while 189 added to existing stakes and 172 trimmed.
The largest buyer was WCM Investment Management, opening a new position worth an estimated $463M. The largest seller was Deutsche Bank, cutting an estimated $88.1M.
- 501 institutional investors held ResMed (RMD) as of Q4 2018, up from 497 in Q3 2018.
- Funds reported $11B of ResMed stock for Q4 2018, up 1.7% quarter-over-quarter.
- 67 funds opened new ResMed positions in Q4 2018 and 60 closed out, a net change of +7 holders.
- The largest ResMed buyer in Q4 2018 was WCM Investment Management, an estimated $463M added.
- The largest ResMed seller in Q4 2018 was Deutsche Bank, an estimated $88.1M sold.
Based on aggregated 13F filings for Q4 2018.